Add To My Watchlist
View My Watchlist

Overall Rating: 67 Bullish

Action to take: BUY
Bullish stocks are expected to outperform the market by 2X over the next 12 months.
67
Priced Based
Momentum
38
Size
1
Volatility
58
Fundamental Based
Value
78
Quality
96
Growth
72
Positive Factors (Top 20%)
Quality: High-quality stocks tend to outperform low-quality stocks.
Negative Factors (Bottom 20%)
Size: Stocks of the largest companies tend to lag the returns of otherwise equally-rated smaller companies.
Collapse Detail
PFE charts & data provided by TradingView

Latest Insights on PFE

Pfizer stock rating PFE Pfizer Stock Ratings for 2023 and Beyond
by Money and Markets Staff January 23, 2023 Investing
Pfizer Inc. (NYSE: PFE) helped the world overcome the worst of the COVID-19 pandemic by developing an innovative vaccine. How does Pfizer stock look now?
Pfizer stock Pfizer’s Boost in Pharmaceutical Race: Stock Power Breakdown
by Fletcher Post October 27, 2022 Investing
Whichever vaccine you may or may not have received, there is no denying the profit health care made. Let's see how Pfizer's stock stands.
cannabis-New York cannabis legalization How Midterms Will Change the Cannabis Market + 3 Stocks to Watch
by Matthew Clark August 19, 2022 Investing
Matt responds to a viewer email about the upcoming midterms elections and the cannabis market. Will favorites like TLRY, CRLF and YOLO hold up?
dividends J.M. Smucker stock SJM dividend investing KMI Kinder Morgan Beat the Bear With 3 Tools: Dividends, Dividends and Dividends
by Contrarian Outlook July 13, 2022 Investing
It’s not easy to be upbeat in a bear market. This goes for people — and especially dividend stocks.
health care stocks Eli Lilly stock LLY 4 Double Discounted Health Care CEFs (Paid Monthly)
by Contrarian Outlook April 20, 2022 Investing
These days, health care is hands-down the most wrongly trashed corner of the market. Here are some funds with potential with a monthly dividend bonus.